Alector, Inc. (ALEC): Price and Financial Metrics
ALEC Price/Volume Stats
| Current price | $1.86 | 52-week high | $8.90 |
| Prev. close | $1.78 | 52-week low | $1.73 |
| Day low | $1.73 | Volume | 4,460,900 |
| Day high | $1.89 | Avg. volume | 763,675 |
| 50-day MA | $3.87 | Dividend yield | N/A |
| 200-day MA | $4.95 | Market Cap | 182.16M |
ALEC Stock Price Chart Interactive Chart >
Alector, Inc. (ALEC) Company Bio
Alector, Inc. operates as a clinical-stage biopharmaceutical company. It develops therapeutics for the treatment of neurodegenerative diseases including frontotemporal dementia (FTD), Alzheimer's disease, and Parkinson's disease. The company was founded by Asa Abeliovich, Errik B. Anderson, Tillman U. Gerngross, and Arnon Rosenthal in May 2013 and is headquartered in South San Francisco, CA
ALEC Price Returns
| 1-mo | -52.79% |
| 3-mo | -65.87% |
| 6-mo | -57.34% |
| 1-year | -76.78% |
| 3-year | -92.16% |
| 5-year | -90.46% |
| YTD | -76.69% |
| 2023 | -13.54% |
| 2022 | -55.30% |
| 2021 | 36.48% |
| 2020 | -12.19% |
| 2019 | N/A |
Loading social stream, please wait...